The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
REBECA: A phase I study of bevacizumab (BEV) and whole-brain radiation therapy (WBRT) for treatment of solid tumors brain metastases (BM), EudraCT: 2009-015977-11.
Christelle Levy
No relevant relationships to disclose
Djelila Allouache
No relevant relationships to disclose
Joelle Lacroix
No relevant relationships to disclose
Audrey Emmanuelle Dugue
No relevant relationships to disclose
Stephane Supiot
No relevant relationships to disclose
Marc-Andre Mahe
No relevant relationships to disclose
Marianne Leheurteur
No relevant relationships to disclose
Chantal Hanzen
No relevant relationships to disclose
Youlia M. Kirova
No relevant relationships to disclose
Francois Campana
No relevant relationships to disclose
Emilie Le Rhun
No relevant relationships to disclose
Louis Gras
No relevant relationships to disclose
Marie-Pierre Sunyach
No relevant relationships to disclose
Iona Hrab
No relevant relationships to disclose
Julien Geffrelot
No relevant relationships to disclose
Katharina Gunzer
No relevant relationships to disclose
Jean-Marc Constans
No relevant relationships to disclose
Jean-Michel Grellard
No relevant relationships to disclose
Benedicte Clarisse
No relevant relationships to disclose
Xavier Paoletti
No relevant relationships to disclose